Bromazolam formulations are a relatively contemporary development in the realm of pharmaceuticals. These minute increments offer a targeted method for delivering bromazolam, a potent CNS depressant. While investigations on bromazolam pellets are still in progress, early findings suggest their potential success in treating a spectrum of ailments.